HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells.

Abstract
Mesangial cells are centrally-located glomerular pericytes with contractile, endocrine, and immunity-regulating functions. These cells are thought to maintain normal glomerular function, since mesangial cell proliferation and extracellular matrix formation are hallmarks of chronic glomerular disease. Vasopressin causes mesangial cell contraction, proliferation and hypertrophy. Consequently, the effects of YM218, a potent, nonpeptide vasopressin V(1A) receptor-selective antagonist, on the growth responses of human mesangial cells to vasopressin were investigated. YM218 showed high affinity for vasopressin V(1A) receptors, exhibiting a K(i) value of 0.18 nM. Vasopressin concentration-dependently increased intracellular Ca(2+) levels and induced hyperplasia and hypertrophy in cultured mesangial cells, YM218 potently inhibited these vasopressin-induced responses. These results clearly show that YM218 has both strong affinity for human mesangial cell vasopressin V(1A) receptors and great potency in inhibiting the vasopressin-induced growth responses of mesangial cells controlled by the vasopressin V(1A) receptors. The hyperplasia and hypertrophy of mesangial cells in vitro caused by vasopressin indicate its possible in vivo role in glomerular disease pathogenesis. Therefore, YM218 is a potent pharmacologic probe to investigate the physiologic and pathophysiologic roles of vasopressin in the development of renal disease.
AuthorsAtsuo Tahara, Junko Tsukada, Yuichi Tomura, Kazuhiro Momose, Takeshi Suzuki, Takeyuki Yatsu, Masayuki Shibasaki
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 538 Issue 1-3 Pg. 32-8 (May 24 2006) ISSN: 0014-2999 [Print] Netherlands
PMID16678155 (Publication Type: Journal Article)
Chemical References
  • 4'-(4,4-difluoro-5-(2-oxo-2-(4-piperidinopiperidino)ethylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl)-2-methyl-3-furanilide
  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines
  • Indoles
  • Piperidines
  • Proteins
  • Pyrrolidines
  • Tritium
  • Vasopressins
  • relcovaptan
  • Calcium
Topics
  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines (pharmacology)
  • Binding, Competitive (drug effects)
  • Calcium (metabolism)
  • Cell Membrane (drug effects, metabolism)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Humans
  • Indoles (pharmacology)
  • Mesangial Cells (drug effects, metabolism, pathology)
  • Piperidines (pharmacology)
  • Proteins (metabolism)
  • Pyrrolidines (pharmacology)
  • Tritium
  • Vasopressins (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: